AnRim Biotechnology Co., Ltd. (ANRim) was founded in 2023. Its core team, hailing from City University of Hong Kong, has over a decade of experience in nanotechnology and biotechnology R&D. The company focuses on integrating nanotechnology with precision medicine, developing gene delivery and detection technologies based on nanoneedle array biochips and has been granted over 20 patents.

We are committed to advancing affordable, next-generation cell therapy and gene editing solutions and becoming an innovative pioneer in this field.